3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Frailty
5
Neoplasms
3
Breast Neoplasms
3
Prostatic Neoplasms
2
Multiple Myeloma
2
Lymphoma
2
Lung Neoplasms
2
Urogenital Neoplasms
1
Solid Neoplasm
1
Sarcopenia
1
Sarcoma
1
Ovarian Neoplasms
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Hepatic Malignancies
1
Hematopoietic and Lymphoid System Neoplasm
1
Hematologic Neoplasms
1
Hematologic Diseases
1
Health Education
1
Head and Neck Neoplasms
1
Communication
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Anatomic Stage I Breast Cancer AJCC v8
1
Interventions
pembrolizumab
69
Nivolumab
67
cabozantinib
45
Ipilimumab
36
Specimen Handling
32
Magnetic Resonance Spectroscopy
32
lenvatinib
26
Axitinib
25
belzutifan
21
Sunitinib
17
Biopsy
15
Radiosurgery
14
CTLA-4 Antigen
13
atezolizumab
12
Everolimus
10
pazopanib
8
fludarabine
8
avelumab
8
Bevacizumab
8
toripalimab
7
cemiplimab
7
Nephrectomy
7
Immunoglobulin G
7
Cyclophosphamide
7
aldesleukin
6
Standard of Care
6
Radiotherapy
6
Blood Specimen Collection
6
spartalizumab
5
palbociclib
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Renal Cell
×
Geriatric Assessment
×
1 year
×
Clear all
No trials found.